Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1996-10-25
1999-05-11
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
514171, 514174, 514211, 5142258, 514356, 514648, 514654, A61K33/26;31/58;31/55;31/54
Patent
active
059026090
ABSTRACT:
This invention pertains to a composition for controlling wound scar production containing a calcium antagonist and a protein synthesis inhibitor. The method can be used to minimize wound scars, such as hypertrophic wound healing disorders keloids and burn scar contractures in humans or other mammals, particularly those individually prone to excesssive scarring Calcium antagonist treatment can also be used to control diseases associated with excessive scarring. such as cirrhosis of the liver, constructive pericarditis Dupuytren's disease of the hand, plantar fibrosis of the foot, and various other fibromatoses.
REFERENCES:
patent: 4690935 (1987-09-01), Taylor et al.
patent: 4806464 (1989-02-01), Spelsberg
patent: 5270171 (1993-12-01), Cercek et al.
patent: 5525513 (1996-06-01), Chen et al.
Askey et al., "The Effect of Weak Electric Fields and Verapamil on Exocytosis in Human Fibroblasts", J.Cell.Biol., Joint Meeting of American Society for Cell Biol. and American Society for Biochem. and Mol. Bio., San Francisco, CA, abt. #1905, p. 336a, Jan. 29-Feb. 2, 1989.
Askey et al., Weak Electric Fields and Verapamil Reduce Exocytosis in Human Fibroblasts, Proceedings Electrochemical Society, Los Angeles, CA, May 7-12, 1989.
Ohmori, S., "Effectiveness of Silastic Sheet Coverage in the Treatment of Scar Keloid (Hypertrophic Scar)," Aesthetic Plastic Surgery, 12:95-99 (1988).
Chen et al., "Voltage Sensitive Calcium Channels in Normal and Transformed 3T3 Fibroblasts," Science, 239:1024-1026 (1988).
Onuma et al., "Electric Field-directed Cell Shape Changes, Displacement and Cytoskeletal Reorganization Are Calcium Dependent," J. Cell. Bio., 106:2069-2075 (1988).
McLeod et al., "Frequency Dependence of Electric Field Modulaltion of Fibroblast Protein Synthesis," Science, 236:1465-1469 (1987).
Abergel et al., "Biochemical Composition of the Connective Tissue in Keloids and Analysis of Collagen Metabolism in Keloid Fibroblast Cultures," J.Invest. Dermatol., 84:384-390 (1985).
Miller, E.A., "Electric Field Modulation of Exocytosis in Human Fibroblasts," B.S. Thesis, Massachusetts Institute of Technology (May, 1987).
Sank et al., "Increased calcium levels alter cellular and molecular events in wound healing", Surgery 106 (6):1141-1148 (1989).
Steinleitner et al., "Use of Diltiazem for Preventing Postoperative Adhesions," J. Reproductive Medicine, 33:891-894 (1988).
Block et al., "Ca.sup.2 -channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells," Proc. Natl. Acad. Sci. USA, 86:2388-2392 (1989).
Lee et al., "Calcium Antagonists Retard Extracellular Matrix Production in Connective Tissue Equivalent," J. Surg. Res., 49:463-466 (1990).
McLeod, K.J., "Modulation of Biosynthesis by Physiologically Relevant Electric Fields," Ph.D. Thesis, Massachusetts Institute of Technology, 1986.
Aggeler, J., "Cytoskeletal Dynamics in Rabbit Synovial Fibroblasts: II. Reformation of Stress Fibers in Cells Rounded by Treatment with Collagenase-Inducing Agents," Cell Motility and the Cytoskeleton, 16:121-132 (1990).
Clark et al., "The response of retroperitoneal fibrosis to tamoxifen," Surgery, 109:502-506 (1991).
Kinzbrunner et al., "Remission of Rapidly Growing Desmoid Tumors after Tamoxifen Therary," Cancer, 52:2201-2204 (1983).
Unemori et al., "Reorganization of Polymerized Actin: A Possible Trigger for Induction of Procollagenase in Fibroblasts Cultured in and on Collagen Gels," J. Cell Bio., 103:1021-1031 (1986).
Smedley et al., "Effect of calmodulin inhibitors on wound healing in Xenopus early embryos," Cytobios., 42:25-32 (1985).
Cohen et al., "Collagen Synthesis in Keloid and Hypertrophic Scar Following Intralesional Use of Triamcinolone," Surg. Forum, 24:521-3 (1973).
Salmela, K., "Comparison of the Effects of Methylprednisolone and Hydrocortisone on Granulation Tissue Development," Scand. J. Plast. Reconstr Surg, 15:87-91 (1981).
Van Bocksmeer et al., "Models for Assessing Scar Tissue Inhibitors," Retina, 5:47-60 (1985).
Lotif et al., "Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment," Int. J. Colorect Dis., 4:30-36 (1989).
Massoud, E., "Traitement des cheloides et des cicatrices hypertophiques par la triamcinolone acetonide," Ann. Chir. Plast., 15(1):54-56 (1970).
Berkow et al., "The Merck Manual of Diagnosis and Therapy," Merck Sharp & Dohme Research Laboratories, Rayway, NJ, p. 2306 (1987).
Lipton et al., "Calcium antogonism by the antioestrogen tamoxifen," Cancer Chemother. Pharmacol., 18(1):17-20 (1986).
McGonigan et al., "The effects of breast cancer chemotherapy on wound healing in the rat," J. Surg. Res., 42(5):560-564 (1987).
Lossnitzer et al., Prevention of Myocardial Cell Necrosis in the Syrian Hamster--Results of Long-Term Treatment, In Hypertrophic Cardiomyopathy: Ther. Role Calcium Antagonists, Kaltenbach et al., eds. pp. 99-114 (1982).
Jarvis William R. A.
Massachusetts Institute of Technology
LandOfFree
Composition for the control of wound scar production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for the control of wound scar production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the control of wound scar production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-244570